Unique ID issued by UMIN | UMIN000059160 |
---|---|
Receipt number | R000065996 |
Scientific Title | A study of the effects of changes in patency of the airway during dental sedation on tissue blood flow and stress. |
Date of disclosure of the study information | 2025/10/01 |
Last modified on | 2025/10/02 20:01:33 |
A study of the relationship between airway and stress during dental sedation.
A study of the relationship between airway and stress during dental sedation.
A study of the effects of changes in patency of the airway during dental sedation on tissue blood flow and stress.
A study of the effects of changes in patency of the airway during dental sedation on tissue blood flow and stress.
Japan |
Dental Anesthesiology
Anesthesiology | Dental medicine |
Others
NO
One of the adverse events in sedation is obstruction of the airway and consequent hypoxemia. Nasopharyngeal tube is one of the ways to improve patency of the airway. This study evaluates the effects of airway obstruction during sedation and changes in patency of the airway induced by nasopharyngeal tube on tissue blood flow, tissue oxygenation, and stress.
Others
This study aims to improve the safety of dental sedation by evaluating the effects of airway obstruction during sedation and changes in patency of the airway by the nasopharyngeal tube on tissue blood flow, tissue oxygenation, and stress.
1) Evaluation of respiration and oxygenation:
1. The number of apneas (pAHI), degree of snoring, peripheral vascular blood flow (PAT amplitude), and arousal state are continuously recorded using the WatchPat 300 (sleep evaluation device).
2. Exhaled end-expiratory partial pressure of carbon dioxide (EtCO2) and capnogram are recorded by capnography. EtCO2 is recorded every 15 minutes in the anesthesia record.
Oxygen saturation is measured by measuring SpO2 using a pulse oximeter.
2) Evaluation of tissue blood flow:
1. Brain tissue blood flow and oxygenation caused by changes in respiration during sedation will be evaluated using NIRO 200nx (Near Infrared Spectroscopy) and recorded continuously.
3) Evaluation of stress:
1. The effects of changes in respiration during sedation on autonomic nervous system activity will be evaluated using my Beat (heart rate variability analyzer) and recorded continuously.
2. Cortisol, sIgA, sIgG, and amylase will be measured using the SOMA CUBE Reader (salivary stress marker analyzer) to evaluate the effects on stress. Saliva samples are collected 2 minutes prior to body position change.
1) Record the subject's basic information:
Age, gender, height, weight, current medical history, medical history, medication status, amount of mouth opening/ distance between mussel hyoid bones/ distance between hyoid bones thyroid cartilage, tongue size, presence of enlarged tonsils, number of remaining teeth, presence of cervical backbending restriction, frequency of habitual snoring.
2) Vital signs during and before and after sedation:
Blood pressure, pulse rate, heart rate, SpO2, respiratory rate
3) Assessment of sedation level:
Evaluated by electroencephalogram monitoring (BIS), OAA/S score, and the definition of sedation depth in the sedation guidelines of the American Society of Anesthesiologists.
4) Subject's Impression:
After sedation, the subject's satisfaction with sedation and discomfort related to the use of the nasopharyngeal tube will be evaluated using the Visual Analogue Scale (VAS).
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
Other |
This study is a Cohot study in which the same subjects were sedated and each parameter was measured before and after the use of a nasopharyngeal tube.
20 | years-old | <= |
60 | years-old | > |
Male and Female
Healthy adults (1 or 2 in the American Society of Anaesthesiologists' Classification of Systemic Conditions (ASA-PS classification))
1) If there is habitual mouth breathing or if the patient is reported to be prone to epistaxis
2) Inflammation or tumour of the nasal cavity, suspected skull base fracture
3) If there is a history of chronic obstructive pulmonary disease (COPD)
4) If allergic to any of the drugs used (Propofol, Midazolam, Flumazenil)
5) If the EEG cannot be measured accurately, e.g. history of epilepsy
6) If the patient is taking antithrombotic or anticoagulant medication
7) If the patient is unable to comply with the no eating or drinking times (no food: 6 hours before the procedure No water: 3 hours before the procedure)
8) If consent to participate in the study cannot be obtained
9) If the principal investigator considers the patient to be unsuitable for participation in the study
20
1st name | HIDETAKA |
Middle name | |
Last name | KURODA |
KANAGAWA DENTAL UNIVERSITY
Department of Anesthesiology, Division of Dental Anesthesiology
2380003
82 Inaoka-cho, Yokosuka-shi, Kanagawa
0468228751
kuroda@kdu.ac.jp
1st name | HIDETAKA |
Middle name | |
Last name | KURODA |
KANAGAWA DENTAL UNIVERSITY
Department of Anesthesiology, Division of Dental Anesthesiology
2380003
82 Inaoka-cho, Yokosuka-shi, Kanagawa
0468228751
kuroda@kdu.ac.jp
KANAGAWA DENTAL UNIVERSITY
none
Other
KANAGAWA DENTAL UNIVERSITY
82 Inaoka-cho, Yokosuka-shi, Kanagawa
0468228751
kenkyo@kdu.ac.jp
NO
神奈川歯科大学附属病院
2025 | Year | 10 | Month | 01 | Day |
Unpublished
Open public recruiting
2025 | Year | 04 | Month | 01 | Day |
2025 | Year | 04 | Month | 18 | Day |
2025 | Year | 10 | Month | 01 | Day |
2026 | Year | 03 | Month | 31 | Day |
2027 | Year | 03 | Month | 31 | Day |
2027 | Year | 03 | Month | 31 | Day |
2027 | Year | 03 | Month | 31 | Day |
2025 | Year | 09 | Month | 22 | Day |
2025 | Year | 10 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065996